PALbociclib Endocrine Therapy Followed by Talazo vs. Talazoz-Atezo Study
Condition(s):Premenopausal HR+/HER2- Metastatic Breast CancerLast Updated:July 27, 2021Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Premenopausal HR+/HER2- Metastatic Breast CancerLast Updated:July 27, 2021Not yet recruiting
Condition(s):Breast Cancer FemaleLast Updated:April 19, 2023Completed
Condition(s):Breast CancerLast Updated:March 27, 2024Active, not recruiting
Condition(s):Breast CancerLast Updated:August 30, 2023Recruiting
Condition(s):Breast CancerLast Updated:April 20, 2020Recruiting
Condition(s):Breast Cancer Female; Hormone Receptor Positive Malignant Neoplasm of BreastLast Updated:March 10, 2023Completed
Condition(s):Breast CancerLast Updated:February 22, 2024Completed
Condition(s):Breast CancerLast Updated:March 20, 2024Active, not recruiting
Condition(s):Breast Cancer RecurrentLast Updated:March 6, 2024Recruiting
Condition(s):Metastatic Breast CancerLast Updated:June 21, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.